Adial Pharmaceuticals, Inc
$0.3269
Stock Quotes & Analysis
ADIL0.97%
$0.3269
Latest AAPL News (Need to figure out how to make this dynamic)
test
Graphene is an excellent conductor of electricity and heat, surpassing traditional materials like silicon, and…
The political winds are shifting, and Wall Street is taking notice. As Donald Trump’s approval…
In the shadows of Silicon Valley’s AI frenzy, a sleeping giant is awakening. While tech…
Adial Pharmaceuticals, IncStatus: Active
Sector: Healthcare
Industry: Biotechnology
Symbol: ADIL
Exchange: NCM
Employees: 4
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
 | 4870 Sadler Road, Glen Allen, VA, United States |
 | 804 487 8196 |
 | https://www.adial.com |